Bacterial species | ESBL-E | pAmpC-E | CIP-RE | CIRE |
---|
n/N (%)a | n/N (%)a | n/N (%)a | n/N (%)a |
---|
Escherichia coli
| 101/107 (94.4) | 13/15 (86.7) | 51/51 (100.0) | 2/6 (33.3) |
Klebsiella pneumoniae
| 3/107 (2.8) | 2/15 (13.3) | – | 2/6 (33.3) |
Klebsiella oxytoca
| – | – | – | 1/6 (16.7) |
Enterobacter cloacae
| 1/107 (0.9) | – | – | – |
Enterobacter aerogenes
| 1/107 (0.9) | – | – | 1/6 (16.7) |
Providencia rettgeri
| 1/107 (0.9) | – | – | – |
Total n/N (%)b | 107/500 (21.4) | 15/500 (3.0) | 51/500 (10.2) | 6/500 (1.2) |
- Abbreviations: ESBL-E Extended-spectrum β-lactamase-producing Enterobacteriaceae; pAmpC-E plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae, CIP-RE Ciprofloxacin-resistant Enterobacteriaceae, CIRE Carbapenem-intermediate or -resistant Enterobacteriaceae
- aIndicates the percentage of bacterial species among ESBL-E (N = 107), pAmpC-E (N = 15), CIP-RE (N = 51), or CIRE (N = 6) isolates
- bIndicates the percentage of ESBL-E, pAmpC-E, CIP-RE and CIRE isolates according to 500 samples